| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 781.10M | 892.10M | 1.06B | 1.10B | 970.70M |
| Gross Profit | 251.70M | 321.40M | 386.80M | 428.20M | 353.60M |
| EBITDA | 7.60M | 28.10M | 49.60M | 80.80M | 74.20M |
| Net Income | -26.80M | -6.00M | 13.40M | 39.10M | 33.50M |
Balance Sheet | |||||
| Total Assets | 294.50M | 355.50M | 415.70M | 474.10M | 446.30M |
| Cash, Cash Equivalents and Short-Term Investments | 49.10M | 68.10M | 95.70M | 123.20M | 142.30M |
| Total Debt | 90.90M | 88.00M | 95.00M | 102.50M | 82.10M |
| Total Liabilities | 193.30M | 217.00M | 250.80M | 290.20M | 271.50M |
| Stockholders Equity | 101.20M | 138.50M | 164.90M | 183.90M | 174.80M |
Cash Flow | |||||
| Free Cash Flow | 7.50M | 9.70M | 29.60M | 22.20M | 20.40M |
| Operating Cash Flow | 8.90M | 19.80M | 45.50M | 38.10M | 33.60M |
| Investing Cash Flow | -5.90M | -9.40M | -14.20M | -15.50M | -12.80M |
| Financing Cash Flow | -21.50M | -33.90M | -52.20M | -47.50M | -27.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | £35.95M | 5.49 | 11.07% | 3.35% | 2.40% | 1101.69% | |
69 Neutral | £190.72M | 12.17 | 7.83% | 6.35% | -13.93% | -48.74% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
54 Neutral | £50.49M | 11.41 | 13.11% | ― | 1.44% | ― | |
48 Neutral | £440.89M | 81.54 | 4.18% | 7.58% | -12.54% | -76.55% | |
46 Neutral | £56.17M | -3.34 | -24.67% | 12.88% | -14.31% | -361.93% | |
45 Neutral | £511.09M | 748.65 | -2.24% | 1.76% | -4.92% | -58.06% |